Status:
TERMINATED
An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
A worldwide study with extension in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug for weight loss on bod...
Eligibility Criteria
Inclusion
- Body Mass Index (BMI) between 27 kg/m2 and 43 kg/m2 and HbA1c between 7.0% and 10%
Exclusion
- History of major psychiatric disorder
- Blood pressure greater than 160/100
- Use of any antihyperglycemic agent other than metformin
- Triglycerides greater then 600 mg/dL
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00430742
Start Date
November 1 2006
End Date
November 1 2008
Last Update
February 13 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.